Lauren Biscaldi is the Managing Editor of Drug Topics.
Drugs to Watch: Current Clinical Trials in Hematology/Oncology
Gastroenterology Pipeline Update: New Treatments for Ulcerative Colitis, Crohn's Disease
ASHP: Adalimumab Biosimilar Pipeline Review
At least 6 adalimumab biosimilars are set to launch in July 2023.
Dermatology Pipeline Updates: Plaque Psoriasis, Atopic Dermatitis and More
Boost Summertime Sales With These Front-End Items
Stock solutions to common summer maladies in the pharmacy's front end.
NCCN Calls on Federal Agencies, Payers, to Take Action on Chemotherapy Drug Shortages
Carboplatin and cisplatin are currently in short supply.
Wildfire Smoke Raises Respiratory Concerns Across Northeastern United States
Air quality in New York City was the worst in the world on Tuesday morning.
Breaking: Merck Files Lawsuit to Halt Medicare Drug Price Negotiations
According to a spokesperson, the company is prepared to take the lawsuit to the Supreme Court.
Overall Survival Rates in AYA Cancer Lack Improvement Seen in Pediatric, Adult Cancer
Overall survival rates for various cancers differed by race.
Immunotherapy-Induced Pneumonitis Common in Patients With NSCLC
Knowledge gaps exist around the timing of pneumonitis onset in patients treated with checkpoint inhibitors.
Acute Cardiac Events Common During Hospitalization for COVID-19
Patients were more likely to require ICU admission.
FDA: Pfizer RSV Vaccine Approved for Use In Older Adults
Abrysvo is the second RSV vaccine approved by the FDA.
FDA Approves Sotagliflozin For Heart Failure Across Full Range of LVEF
The medication is broadly approved for heart failure with preserved or reduced ejection fraction.
FDA Approves Buprenorphine Extended-Release Subcutaneous Injection for OUD
This treatment is the first and only long-acting buprenorphine injectable with weekly and monthly doses.
FDA Approves Fezolinetant, A Novel Therapy for Vasomotor Symptoms in Menopause
Vasomotor symptoms include hot flashes and night sweats, which can negatively impact a woman's quality of life.
Regardless of Age and Season, Patients Should be Screened for a Range of Respiratory Viruses
Patients should be screened regardless of age, gender, or time of year.
Roflumilast Foam 0.3% Evaluated for Seborrheic Dermatitis in Adults
Roflumilast foam can help address the unmet need for an effective, cosmetically tolerable treatment for seborrheic dermatitis.
Improving Adherence to Skin Self-examination in High-Risk Individuals
Patient adherence to self-management strategies can be difficult.
Tralokinumab Efficacy, Tolerability in Adolescents With AD Evaluated
There are only a few long-term treatments currently available for adolescents with moderate to severe AD.
Breaking: FDA Approves First-Ever RSV Vaccine
The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.
Inaccurate Labeling of Melatonin Gummies Cause for Concern for Pediatric Consumption
Dupilumab Therapy Improves Outcomes in Chronic Rhinosinusitis With Asthma
FDA Approves Expanded Indication for Atogepant for Prevention of Chronic Migraine
Only the 60 mg dose of atogepant is approved for chronic migraine prevention.
FDA Amends Moderna, Pfizer EUAs to Simplify Use of Bivalent COVID-19 Vaccines
Monovalent vaccines by these manufacturers are no longer authorized for use in the United States.
Breaking: HHS Extends PREP Act Authority for Pharmacists, Pharmacy Technicians
HHS Secretary Xavier Becerra will release an amendment to the declaration in the coming weeks.
AAP Members Celebrate Their Independent Pharmacy Stories
Four independent pharmacists shared their journeys to become pharmacy owners.
Biden Administration Announces $5 Billion Investment in COVID-19 Vaccine, Treatment Development
Project NextGen will focus on the development of vaccines and long-lasting monoclonal antibody COVID-19 treatments.
Last Chance to Register: Don’t Miss the Next Total Pharmacy Solutions Summit
The theme of the upcoming Summit is the Expansion of Services Within Independent Pharmacy.
Video: Tips for Medication Management During Ramadan
Pharmacists can provide support and guidance to patients during their month of fasting.
Breaking: FDA Approves OTC Designation for Naloxone Nasal Spray
Naloxone hydrochloride nasal spray (Narcan) 4 mg is expected to be available over the counter in late summer 2023.
2 Clarke Drive Cranbury, NJ 08512